Literature DB >> 2342996

Vacuolar myelopathy in AIDS. A morphological analysis.

J Artigas1, G Grosse, F Niedobitek.   

Abstract

Between 1986 and 1988 we studied the spinal cord of 40 patients dying of AIDS. Transverse and longitudinal sections from a minimum of four levels of the spinal cord were examined by means of conventional histology, immunohistochemistry and electron microscopy. Out of 22 cases there were 6 showing a mild, 11 a moderate and 5 a severe myelopathy. Among these cases with severe myelopathy, vacuolar degeneration of the posterior, lateral, and anterior columns of the white matter, which are typical findings of vacuolar myelopathy (VM), were present. Cervical and thoracic cords were affected in all cases, the lumbal cord, however, in only two. Fusiform vacuoles, 30 to 180 microns in diameter and 200 to 500 microns in length, could be seen rising between the axolemma and the myelin sheath. Most of them were still containing an axon cylinder. Foamy phagocytic cells, phagocytosing axons of apparently preserved structure were found within the vacuoles. These foamy macrophages contained rests of axons in their cytoplasm. However, only one case with severe tissue disruption exhibited myelin debris as well. Our morphological findings suggest that in VM of AIDS a process of phagocytosis directed against the axon cylinders occurs simultaneously with vacuolar degeneration of the white matter of the spinal cord. The results suggest furthermore that VM, especially its moderate form, appears to be a more frequent condition than previously assumed.

Entities:  

Mesh:

Year:  1990        PMID: 2342996     DOI: 10.1016/S0344-0338(11)80540-6

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  8 in total

1.  Pilot study of intravenous immunoglobulin in HIV-associated myelopathy.

Authors:  Katia Cikurel; Lauren Schiff; David M Simpson
Journal:  AIDS Patient Care STDS       Date:  2009-02       Impact factor: 5.078

2.  HIV-Associated Vacuolar Encephalomyelopathy.

Authors:  Gregory R Madden; Molly E Fleece; Akriti Gupta; M Beatriz S Lopes; Scott K Heysell; Christopher J Arnold; Brian Wispelwey
Journal:  Open Forum Infect Dis       Date:  2019-10-01       Impact factor: 3.835

3.  MR findings in AIDS-associated myelopathy.

Authors:  J Chong; A Di Rocco; M Tagliati; F Danisi; D M Simpson; S W Atlas
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

4.  Spinal tract pathology in AIDS: postmortem MRI correlation with neuropathology.

Authors:  C G Santosh; J E Bell; J J Best
Journal:  Neuroradiology       Date:  1995-02       Impact factor: 2.804

5.  Cytomegalovirus myelitis in perinatally acquired HIV.

Authors:  T Güngör; M Funk; R Linde; G Jacobi; M Horn; W Kreuz
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

6.  Lower-extremity Dynamometry as a Novel Outcome Measure in a Double-blind, Placebo-controlled, Feasibility Trial of Intravenous Immunoglobulin (IVIG) for HIV-associated Myelopathy.

Authors:  Jessica Robinson-Papp; Mary Catherine George; Alexandra Nmashie; Donald Weisz; David M Simpson
Journal:  Innov Clin Neurosci       Date:  2018-02-01

7.  Diffusion tensor MR imaging (DTI) metrics in the cervical spinal cord in asymptomatic HIV-positive patients.

Authors:  Christina Mueller-Mang; Meng Law; Thomas Mang; Julia Fruehwald-Pallamar; Michael Weber; Majda M Thurnher
Journal:  Neuroradiology       Date:  2010-11-03       Impact factor: 2.804

8.  AIDS-myelopathy. A neuropathological study.

Authors:  M Bergmann; F Gullotta; K Kuchelmeister; T Masini; G Angeli
Journal:  Pathol Res Pract       Date:  1993-02       Impact factor: 3.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.